Company / Cash per Share
Minerva Neurosciences, Inc. Cash per Share History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.05
FY2024
5-year range
$0.65 / $7.66
FY2020-FY2024
Trend
-60.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 8 years, ranging from $0.55 in FY2019 to $7.66 in FY2023.
Based on SEC 10-K filings.
3.05 in FY2024 with a 5-year CAGR of +40.9%.
Declined from $6.76 to $3.05 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +29.0%
- 5-Year CAGR
- +40.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, cash per share decreased 60.1% year-over-year.
- Peak cash per share was recorded in FY2023.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.05 | -60.1% |
| FY2023 | $7.66 | +13.4% |
| FY2022 | $6.76 | +375.3% |
| FY2021 | $1.42 | +119.2% |
| FY2020 | $0.65 | +18.0% |
| FY2019 | $0.55 | -57.6% |
| FY2018 | $1.30 | +74.3% |
| FY2017 | $0.74 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026